Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Yield10 Bioscience, Inc. YTEN
$2.94
-$0.03 (-1.01%)
На 18:01, 12 мая 2023
+257.14%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
17005188.00000000
-
week52high
4.19
-
week52low
1.63
-
Revenue
450000
-
P/E TTM
-1
-
Beta
1.81280200
-
EPS
-2.77000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 10:59
Описание компании
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Univest Securities | Buy | 03 мая 2022 г. | |
| Lake Street | Buy | 21 апр 2022 г. | |
| Maxim Group | Buy | Buy | 10 мар 2022 г. |
| National Securities | Neutral | Buy | 25 ноя 2020 г. |
| Maxim Group | Buy | 25 ноя 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BRUM LYNNE H | A | 18000 | 18000 | 12 янв 2023 г. |
| HAASER CHARLES B | A | 18000 | 18000 | 12 янв 2023 г. |
| Snell Kristi | A | 30000 | 30000 | 12 янв 2023 г. |
| Peoples Oliver P | A | 65000 | 65000 | 12 янв 2023 г. |
| Sinskey Anthony J | D | 12309 | 5000 | 03 янв 2023 г. |
| VAN NOSTRAND ROBERT L | A | 2109 | 2109 | 31 дек 2022 г. |
| Sinskey Anthony J | D | 3590 | 3590 | 31 дек 2022 г. |
| LOH WILLIE | A | 10000 | 10000 | 04 окт 2022 г. |
| Sinskey Anthony J | A | 2761 | 2761 | 30 сент 2022 г. |
| VAN NOSTRAND ROBERT L | A | 1601 | 1601 | 30 сент 2022 г. |
Новостная лента
Yield10 Bioscience, Inc. (YTEN) Q1 2023 Earnings Call Transcript
Seeking Alpha
10 мая 2023 г. в 20:44
Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Lynne Brum - Vice President of Planning and Corporate Communications Oliver Peoples - President and Chief Executive Officer Kristi Snell - Vice President of Research and Chief Science Officer Chuck Haaser - Chief Accounting Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Anthony Vendetti - Maxim Group Sameer Joshi - H.C. Wainwright Operator Welcome to the First Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience.
Yield10 Bioscience to Announce First Quarter 2023 Financial Results and Host a Conference Call on Wednesday, May 10, 2023
GlobeNewsWire
04 мая 2023 г. в 08:31
WOBURN, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2023 financial results and provide a corporate update on Wednesday, May 10, 2023.
Yield10 Bioscience, Inc. (YTEN) Q4 2022 Earnings Call Transcript
Seeking Alpha
14 мар 2023 г. в 20:31
Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q4 2022 Earnings Conference Call March 14, 2023 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Snell – Vice President of Research and Chief Science Officer Chuck Haaser – Chief Accounting Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Anthony Vendetti - Maxim Group Sameer Joshi - H.C. Wainwright Operator Greeting and welcome to the Fourth Quarter 2022 Financial Results and Business Update Conference Call for Yield10 Bioscience.
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023
GlobeNewsWire
08 мар 2023 г. в 08:32
WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2022 financial results and provide a corporate update on Tuesday, March 14, 2023.
3 Under-$3 Consumer Staple Stocks Wall Street Analysts Recommend Buying
Zacks Investment Research
28 дек 2022 г. в 12:21
Yield10 Bioscience (YTEN), The Alkaline Water Company (WTER) and Benson Hill (BHIL) are low-priced and well-ranked consumer staple companies, which look well-placed for 2023 on the back of their robust fundamentals.